bibliographicCitation |
Nomura S, Arai T, Takeuchi S, Masui A, Wakamatsu A, Harada Y. Ultiva® (remifentanil hydrochloride), intravenous dose of 2mg, 5mg: pharmacological and clinical profile. Folia Pharmacol. Jpn. 2007;130(4):321–9. doi: 10.1254/fpj.130.321. |